- Home
- SFD vs LEGN Comparison
SFD vs LEGN Comparison
Compare SFD & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFD
- LEGN
- Stock Information
- Founded
- SFD 1936
- LEGN 2014
- Country
- SFD United States
- LEGN United States
- Employees
- SFD N/A
- LEGN N/A
- Industry
- SFD
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- SFD
- LEGN Health Care
- Exchange
- SFD NYSE
- LEGN Nasdaq
- Market Cap
- SFD 7.7B
- LEGN 7.0B
- IPO Year
- SFD 2025
- LEGN 2020
- Fundamental
- Price
- SFD $22.47
- LEGN $31.78
- Analyst Decision
- SFD Strong Buy
- LEGN Strong Buy
- Analyst Count
- SFD 5
- LEGN 13
- Target Price
- SFD $28.60
- LEGN $79.42
- AVG Volume (30 Days)
- SFD 765.3K
- LEGN 1.5M
- Earning Date
- SFD 04-29-2025
- LEGN 05-13-2025
- Dividend Yield
- SFD 2.23%
- LEGN N/A
- EPS Growth
- SFD 16.88
- LEGN N/A
- EPS
- SFD 2.67
- LEGN N/A
- Revenue
- SFD $14,469,000,000.00
- LEGN $627,241,000.00
- Revenue This Year
- SFD $5.86
- LEGN $65.96
- Revenue Next Year
- SFD $0.78
- LEGN $52.55
- P/E Ratio
- SFD $9.64
- LEGN N/A
- Revenue Growth
- SFD N/A
- LEGN 119.97
- 52 Week Low
- SFD $18.43
- LEGN $29.27
- 52 Week High
- SFD $23.45
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- SFD N/A
- LEGN 41.49
- Support Level
- SFD N/A
- LEGN $30.25
- Resistance Level
- SFD N/A
- LEGN $35.81
- Average True Range (ATR)
- SFD 0.00
- LEGN 1.45
- MACD
- SFD 0.00
- LEGN -0.18
- Stochastic Oscillator
- SFD 0.00
- LEGN 27.58
About SFD SMITHFIELD FOODS INC
Smithfield Foods Inc is a hog producer and pork processor based in the United States of America. The company conducts its operations through three reportable segments: Packaged Meats, Fresh Pork, and Hog Production. The company generates the majority of its revenue from the Packaged Meats segment. The Packaged Meats segment consists of the company's U.S. operations that process fresh meat into a wide variety of packaged meats products, including bacon, sausage, hot dogs, deli and lunch meats, dry sausage products (such as pepperoni and genoa), ham products, ready-to-eat products and prepared foods (such as pre-cooked entrees, bacon and sausage).
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.